Ameriprise’s Arteris AIP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.94M Buy
81,108
+7,911
+11% +$253K ﹤0.01% 2709
2026
Q1
$1.2M Buy
73,197
+8,440
+13% +$134K ﹤0.01% 3210
2025
Q4
$1M Buy
64,757
+1,685
+3% +$24.4K ﹤0.01% 3328
2025
Q3
$637K Sell
63,072
-14,829
-19% -$141K ﹤0.01% 3539
2025
Q2
$742K Buy
+77,901
New +$574K ﹤0.01% 3388
2024
Q1
Sell
-174,880
Closed -$1.03M 3845
2023
Q4
$1.03M Sell
174,880
-26,604
-13% -$150K ﹤0.01% 3175
2023
Q3
$1.31M Buy
201,484
+42,762
+27% +$294K ﹤0.01% 3024
2023
Q2
$1.08M Buy
158,722
+36,869
+30% +$199K ﹤0.01% 3138
2023
Q1
$515K Buy
+121,853
New +$637K ﹤0.01% 3421

Other funds holding AIP

Ameriprise's AIP Position: Q2 2026 in Review

Ameriprise increased its Arteris (AIP) stake by 11% in Q2 2026, buying an estimated $253K and bringing the position to 81,108 shares worth $3.94M. The position accounts for ﹤0.01% of the portfolio, ranked #2709.

Ameriprise first reported a position in AIP in Q1 2023 and has held it in 9 quarters since. 211 funds tracked by Wall St. Rank hold AIP as of Q2 2026.

  • Ameriprise held 81,108 shares of Arteris worth $3.94M as of Q2 2026.
  • Ameriprise bought 7,911 Arteris shares in Q2 2026, an estimated $253K.
  • Arteris made up ﹤0.01% of Ameriprise's portfolio in Q2 2026, its #2709 holding.
  • Ameriprise first reported a position in Arteris in Q1 2023 and has held it in 9 quarters since.
  • 211 funds tracked by Wall St. Rank held Arteris as of Q2 2026.

Based on Ameriprise's 13F filing for Q2 2026, filed 14 Aug 2026.